Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMultiple MyelomaPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMelphalanAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCombined Modality TherapyTreatment OutcomeBone Marrow CellsRemission InductionSalvage TherapyStem CellsCyclophosphamideDisease-Free SurvivalLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationEtoposideBone Marrow PurgingRecurrenceHodgkin DiseaseGraft vs Host DiseaseCarmustineCytarabineHematopoietic Stem CellsMyeloablative AgonistsLiver TransplantationSurvival RateWhole-Body IrradiationGraft SurvivalSurvival AnalysisHematologic NeoplasmsVincristineAntigens, CD34Retrospective StudiesBusulfanThiotepaPrognosisGranulocyte Colony-Stimulating FactorDoxorubicinTime FactorsFollow-Up StudiesKidney TransplantationDexamethasoneLymphoma, Mantle-CellLeukapheresisAmyloidosisCell TransplantationBone and BonesAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedThalidomideBoronic AcidsTransplantation ChimeraPyrazinesAntineoplastic AgentsLymphomaTissue DonorsMesenchymal Stem Cell TransplantationLymphoma, FollicularPrednisoneLymphoma, T-Cell, PeripheralNeoplasm, ResidualLeukemia, Myeloid, AcuteAutograftsIfosfamideHematopoiesisCord Blood Stem Cell TransplantationMyelodysplastic SyndromesImmunosuppressive AgentsHeart TransplantationCell DifferentiationInduction ChemotherapyPodophyllotoxinLung TransplantationLeukemiaIdarubicinLymphoma, Large B-Cell, DiffuseAntibodies, MonoclonalBlood Component RemovalCells, CulturedProspective StudiesHistocompatibility TestingMaintenance ChemotherapyFeasibility StudiesGraft RejectionTransplantation ImmunologyLymphoma, B-CellFlow CytometryT-LymphocytesLeukemia, MyeloidOrgan TransplantationBone Marrow DiseasesHistocompatibilityNeoplasm Recurrence, LocalMitoxantrone